Q2 2024 · 13F-HR/A
Stonepine Capital Management, LLCholdings as filed
Filed 2024-08-21 · accession 0000935836-24-000540
$109.6M
Reported value
25
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 000899104 | ADMA | ADMA BIOLOGICS INC | $20.9M | 19.1% | 1,870,000 | Common | SOLE |
| 016259202 | — | ALIMERA SCIENCES INC | $19.5M | 17.8% | 3,511,816 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $18.0M | 16.4% | 1,657,611 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV-SPON ADR | $12.0M | 11.0% | 485,000 | Common | SOLE |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $7.2M | 6.57% | 2,800,000 | Common | SOLE |
| 98419J206 | XOMA | XOMA CORP | $5.9M | 5.41% | 250,129 | Common | SOLE |
| 035255108 | ANIK | ANIKA THERAPEUTICS INC | $4.2M | 3.82% | 165,397 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $2.9M | 2.68% | 625,645 | Common | SOLE |
| 766559702 | RIGL | RIGEL PHARMACEUTICALS INC | $2.5M | 2.29% | 305,000 | Common | SOLE |
| 68404V100 | — | OPTINOSE INC | $2.4M | 2.23% | 2,350,010 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $2.1M | 1.93% | 1,927,446 | Common | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $1.8M | 1.67% | 421,703 | Common | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $1.7M | 1.56% | 300,000 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $1.6M | 1.49% | 1,239,199 | Common | SOLE |
| 054754858 | AYTU | AYTU BIOPHARMA INC | $1.4M | 1.26% | 472,469 | Common | SOLE |
| 49721T309 | EYEGEUR | KIORA PHARMACEUTICALS INC | $840,000 | 0.77% | 200,000 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $737,430 | 0.67% | 609,446 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $723,620 | 0.66% | 66,084 | Common | SOLE |
| 30068X103 | XGN | EXAGEN INC | $652,829 | 0.60% | 358,697 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $630,271 | 0.58% | 1,050,452 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $558,298 | 0.51% | 137,174 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $385,000 | 0.35% | 100,000 | Common | SOLE |
| 29772L108 | ETON | ETON PHARMACEUTICALS INC | $361,900 | 0.33% | 110,000 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $313,038 | 0.29% | 48,012 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $81,250 | 0.07% | 5,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.